AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Volterra, Inc. engages in the provision of platform and infrastructure services to distribute data and applications. It offers autonomous robotics, automated manufacturing, public safety infrastructure, and distributed 5G networks. The company was founded by Ankur Singla and Harshad Nakil and is headquartered in Santa Clara, CA.

Tillotts is a leading international specialty pharmaceutical company with an established presence in Europe and in the rest of the world. Tillotts markets its own products such as Asacol™ and Entocort™ as well as in-licensed products in over 65 countries through its affiliates within Europe and a network of gastroenterology-focused partners throughout the world. Tillotts is part of the Japanese Zeria Group.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

ConvaTec Ltd. engages in the development, manufacture and marketing of medical products. It products include the proprietary aquace and hydro fiber technology, connate moldable technology, flexi seal, fecal management system and duoderm dressings. The company was founded in 1978 and is headquartered in Deeside, the United Kingdom.

Vaxart is a clinical-stage company focused on developing oral recombinant protein vaccines based on its proprietary oral vaccine platform and direct-acting antivirals to treat infections that have limited therapeutic options. Vaxart’s oral vaccines are designed to generate broad and durable immune responses that protect against a wide range of infectious diseases and may be useful for the treatment of chronic viral infections and cancer. Vaxart’s oral vaccines are administered using a convenient room temperature-stable tablet, rather than by injection. Vaxart believes that tablet vaccines are easier to distribute and administer than injectable vaccines, and have the potential to significantly increase vaccination rates. Vaxart’s development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV). Through the merger, Vaxart also acquired antiviral drug candidates, including teslexivir (BTA074), an antiviral treatment for condyloma caused by HPV types 6 and 11.

Ethicon Endo-Surgery, Inc. manufactures surgical devices and equipments. Its products include the ENDOPATH XCEL access system, CONTOUR curved cutter stapler, HARMONIC ultrasonic cutting and coagulation surgical devices and the MAMMOTOME breast biopsy system. The company was founded in 1992 and is headquartered in Cincinnati, OH.

Swedish Orphan Biovitrum engages in the development, marketing, and distribution of orphan products and specialty pharmaceuticals. It offers drugs for the treatment of rare and life-threatening diseases, such as cardiology, diseases affecting immunocompromised patients, genetic disorders, haematology, infectious diseases, metabolic disorders, oncology, palliative care, poison control, respiratory diseases, and urology. In 2009, Swedish Orphan International AB merged with [Biovitrum](/organization/biovitrum), and the combined company has subsequently been rebranded as Swedish Orphan Biovitrum. The company markets its products in Europe, North American, and Japan and is headquartered in Stockholm, Sweden.

Part of Cosmo Pharmaceuticals NV, Cosmo Technologies Ltd. is an Irish company located in Dublin that manufactures and distributes pharmaceutical products. Salix Pharmaceuticals Ltd., now part of Bausch Health Cos., Inc. acquired Cosmo Technologies Ltd. from Cosmo Pharmaceuticals SA.\nThe company says this about itself: COSMO designs, manufactures and markets family-safe technology products. Committed to the idea that technology should be designed for families, not just repurposed from other segments, COSMO is pioneering new product categories. At the center of its offerings is its mobile application, COSMO: Mission Control. This hub for managing connected devices and family software is meant for families who are seeking a new way of doing technology.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Biocodex SA develops and markets pharmaceutical products. Its services include Gastroentorology, Neurology and Psychiatry, pain treatment, and degenerative Osteoarthritis treatment. The company was founded in 1953 and is headquartered in Gentilly, France.

MaaT Pharma, a clinical stage company, has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating a range of cancers and Graft-versus-Host-Disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into improving outcomes of immunotherapy in solid tumors, we have built a powerful discovery and analysis platform, GutPrint®, to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions.

G.D. Searle, LLC is a wholly owned trademark of Pfizer. It is currently used mainly as a distribution trademark for various pharmaceuticals that were developed by G. D. Searle & Company (often referred to as Searle). Prior to its 1985 merger with Monsanto, Searle was a company focusing on life sciences, specifically pharmaceuticals, agriculture, and animal health.

Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany.

Leading BioSciences, Inc. (LBS) is a biopharmaceutical company that has developed a revolutionary medical platform based on the science of autodigestion. The company’s lead candidate (LB1148) is a therapeutic for severe sepsis, septic shock, and multi-organ failure. In addition, the company is developing a breath and blood diagnostic for early detection of acute shock and multi-organ failure. This therapy is part of an overall product design that includes the pharmaceutical formulation (LB1148) and the delivery device. To date, this new medical platform has produced 14 different products, therapies, and medical devices each with their own distinct patents and exclusive licenses.

Applied Medical Resources Corp. provides medical surgical devices. It offers products for cardiac and vascular surgery, general surgery, urology, colorectal surgery and OBGYN surgery devices. The firm's devices include abdominal access, endopyelotomy, endoureterotomy, hand access laparoscopy, graspers, wound retractor and ureteroscopy systems. The company was founded by Said S. Hilal in 1987 and is headquartered in Rancho Santa Margarita, CA.

AnaBio is a technology provider that is focused on commercial offerings of environmentally sustainable, science-based, proven technology solutions for the food, feed and pharmaceutical industries.

Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. is a company headquartered in Edison, NJ, that manufactures pharmaceuticals for kidney transplant patients.\nThe company says this about itself: Veloxis Pharmaceuticals, Inc, an Asahi Kasei company, is a fully integrated specialty pharmaceutical company committed to improving the lives of transplant patients. Headquartered in Cary, North Carolina, USA, Veloxis is focused on the global development and commercialization of medications utilized by transplant patients and by patients with serious related diseases.

Manufactures pharmaceuticals and diagnostic substances